The North America Molecular Diagnostics Market Size is poised to grow at a growth rate of 6.8% CAGR during the forecast period (2016-2022).
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes. High prevalence of Infectious diseases in USA is growing the demand for molecular diagnostic market. According to the Centers of Diseases Control and Prevention, Hepatics C is the leading cause of death in America. In 2014, deaths associated with Hepatics C were all-time high of 19,659. Currently, around 3.5 million Americans are still living with Hepatic C. Additionally; Tuberculosis is also becoming one of the leading causes of death. According to World Health Organisation (WHO), tuberculosis, malaria and AIDS have caused over 300 million illnesses and more than 5 million deaths each year worldwide and the most effected region is North America. Hence, it could be expected that high prevelance of diseases could result in growth of molecular devices market in North America.
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing. Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes.
Based on Country, market is segmented into US, Canada and Mexico.The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
Global Molecular Diagnostics Market
Europe Molecular Diagnostics Market
Asia Pacific Molecular Diagnostics Market
LAMEA Molecular Diagnostics Market
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 